In recent years, PARP inhibitors are changing the therapeutic landscape of ovarian cancer, with maintenance therapy extending the duration of sustained remission after platinum-containing chemotherapy ...
By successfully turning the “cold” tumor into “hot” – transforming the tumor microenvironment from having low immune activity to an active immune environment – ERNA-101 may not only lead to improved ...
Emory University and researchers at Emory's Winship Cancer Institute have secured up to $17.6 million from ARPA-H to develop "MarginCall," an innovative AI imaging technology aimed at enhancing ...